Related Experiment Video

Updated: Jun 9, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Skin diseases associated with hepatitis C virus: facts and controversies

Alfredo Rebora1

  • 1Department of Endocrinological and Medical Sciences, University of Genoa, Genova, Italy. rebdermo@unige.it

Clinics in Dermatology
|August 28, 2010
PubMed

Insights

Hepatitis C virus (HCV) can cause systemic issues like mixed cryoglobulinemia and autoimmune disorders. Dermatologists play a key role in identifying patients experiencing these HCV-related conditions.

Area of Science:

  • Hepatology
  • Immunology
  • Dermatology

Background:

  • Hepatitis C virus (HCV) is a prevalent infectious agent linked to various systemic disorders.
  • HCV is a primary cause of porphyria cutanea tarda and lichen planus in hyperendemic regions.
  • Autoimmune conditions, including sicca syndrome and vasculitides, are frequently associated with HCV infection.

Purpose of the Study:

  • To highlight the association between Hepatitis C virus infection and systemic autoimmune disorders.
  • To emphasize the role of Interferon-a2b in potentially inducing autoimmune side effects.
  • To underscore the importance of dermatologists in the early detection of HCV-related conditions.

Main Methods:

  • Review of existing literature on Hepatitis C virus and associated systemic disorders.
  • Analysis of clinical manifestations linking HCV to autoimmune conditions.
  • Examination of Interferon-a2b's role in iatrogenic autoimmunity.

Main Results:

  • Hepatitis C virus is implicated in systemic disorders such as mixed cryoglobulinemia.
  • HCV is a leading cause of porphyria cutanea tarda and lichen planus in endemic areas.
  • Interferon-a2b therapy can precipitate cell-mediated autoimmune side effects.

Conclusions:

  • Dermatologists are crucial in the timely identification of patients with HCV-associated autoimmune disorders.
  • Understanding the link between HCV and systemic diseases aids in comprehensive patient management.
  • Early diagnosis and intervention can mitigate the impact of HCV-related autoimmune complications.

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...